Completed NA INTERVENTIONAL 3-arm NCT01767324

Site Selection for Intracutaneous Saline Delivery

Exploratory Evaluation of Injection Sites in Healthy Subjects Receiving Saline Delivered by a Non-Significant Risk Investigational Device Utilizing a Micro-Needle Array

Sponsor: Accelovance

Conditions Intracutaneous Drug Delivery

Interventions Injection to deltoid Injection to forearm Injection to thigh

Updated 6 times since 2017 Last updated: Jul 31, 2017 Started: Dec 31, 2012 Primary completion: Dec 31, 2012 Completion: Dec 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Intracutaneous Drug Delivery and is currently completed. Accelovance leads this study, which shows 6 recorded versions since 2012 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Aug 2017 — Jun 2018 [monthly]

Completed NA

▶ Show 1 earlier version

Jan 2017 — Aug 2017 [monthly]

Completed NA

First recorded

Dec 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Accelovance
FluGen Inc

Data source: FluGen Inc

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Melbourne, United States